PipFarm has just launched an exciting festive offer that is sure to catch the attention of traders looking to expand their portfolios. The firm is offering a $100 discount on its popular 100K trading account, bringing the price down from $550 to $450. This special offer is part of their holiday celebrations and is available for a limited time only.
To take advantage of this offer, traders can use the promo code PIPMAGIC100 during checkout. With the offer ending in less than 48 hours, interested participants have to act quickly to secure this exclusive deal.
Celebrate Holidays with PipFarm Festive Offer: Limited Time!
PipFarm’s 100K account is one of their most sought-after offerings, giving traders access to a sizable trading balance while allowing them to manage risk effectively. Traders who qualify for this account have the potential to trade with leverage while enjoying the security of working with a reputable firm. PipFarm is famous for its trader-friendly conditions, providing traders with the tools and resources needed to succeed in the competitive world of forex and stock market trading.
The festive offer is a great opportunity for both professional traders and newcomers to the industry. Whether you’re looking to upgrade your current account or start fresh with a larger balance, the $100 discount makes PipFarm’s 100K account more accessible than ever before.
As the deadline approaches, traders are urged to take swift action and not miss out on this time-sensitive offer. For more information on how to participate, visit PipFarm’s official website and enter the code PIPMAGIC100 at checkout to enjoy this holiday discount before it’s too late.
About the Firm
PipFarm is a proprietary trading firm that allows traders to join and trade their capital. This can be achieved by traders successfully passing the one-step evaluation and start managing a funded account. The company is not all about funding. It prioritizes trader growth, provides support, and celebrates traders’ milestones.
Also, don’t forget to read the Review.